U.S. Food and Drug Administration
Performance Plan
2002
FDA organizes its resources into seven "programs" that coincide with the organization
of the President's annual budget. These programs constitute the major sections
in Part Two of the performance plan. The Tobacco program ended abruptly in FY
2000 when the United States Supreme Court affirmed that FDA lacks jurisdiction
to regulate tobacco products.
- Foods -- Promotes and protects the public health and economic interest
by ensuring that the food supply is safe, nutritious, wholesome, and honestly
labeled. The program also ensures that cosmetics are safe and properly labeled.
- Human Drugs -- Ensures that all drug products used for the prevention,
diagnosis, and treatment of disease are safe and effective; and that information
on proper use is available to all users.
- Biologics -- Ensures the safety, potency, and effectiveness of biological
products for the prevention, diagnosis, and treatment of disease. This includes
blood and blood products, blood test kits, vaccines, therapeutic agents, and
other biological products.
- Medical Devices and Radiological Health -- Ensures that medical
devices are safe, effective, and properly labeled; and that the public is
not exposed to unnecessary radiation from medical, industrial, and consumer
products.
- Animal Drugs and Feeds -- Ensures that only safe and effective animal
drugs, devices, feeds, and food additives are marketed; and that foods from
animals that are administered drugs are safe for human consumption.
- National Center for Toxicological Research -- Conducts scientific
research to develop standards and improve risk assessment for regulatory applications.
- Tobacco -- The Tobacco program worked to reduce young people's use
of tobacco through education, enforcement, and partnerships with CDC and other
Federal and state health agencies. On August 23, 1996 FDA issued its final
regulation on tobacco products. From February 28, 1997 until March 21, 2000,
when the Supreme Court ruled, ending the program, FDA enforced the age and
photo identification restrictions of the rule. During this time, FDA contracted
with all 50 states to conduct nearly 200,000 compliance checks of retailers.
In Part Two of the Performance Plan, each of FDA's programs has outlined strategies
and identified performance goals that are aligned with and operationalize the
Agency's overall strategic framework.
Previous | Table
of Contents | Next